I-Orlistat powder, ekwabizwa ngokuba yi-Xenical okanye i-Alli. I-Orlistatt powder yenzelwe ukunyanga ukukhuluphala kunye nokunceda ukunciphisa umzimba. Umsebenzi wayo ophambili kukuthintela ukufakwa kwamanqatha kukutya komntu ngokusebenza njenge-lipase inhibitor, ngaloo ndlela kunciphisa ukubamba kwe-caloric. Yenzelwe ukusetyenziswa ngokudibeneyo nomboneleli wokhathalelo wezempilo-ogadwe yinciphisa-ikhalori yokutya.
igama | Orlistat |
CAS | 96829-58-2 |
Ukungcola | 98% |
Igama leKhemikhali | Orlistat |
Iintetho ezifanayo | I-Tetrahydrolipstatin Xenical Alli |
I-Molecular Formula | C29H53NO5 |
Isisindo somzimba | 495.7 g / mol |
Indawo yokunyibilika | / |
InChI Key | AHLBNYSZXLDEJQ-FWEHEUNISA-N |
imo | solid |
Kubonakala | Umgubo omhlophe |
Ubomi obulicla | Iiyure ezi-1-2 |
Umzimba | Ukunyibilika kwamanzi: Ngokukodwa ngokunganyibiliki |
yoGcino Imeko | Gcina kwisitya esitywiniweyo somoya, gcina umoya ungaphandle, ukhuselekile kubushushu, ukukhanya kunye nokufuma. |
isicelo | Sebenzisa ukunciphisa umzimba okanye uneengxaki zonyango ezinxulumene nobunzima |
UXwebhu loVavanyo | iyafumaneka |
I-Orlistat powder sisiyobisi esenzelwe ukunyanga ukukhuluphala. Kuthengiswa njengeyeza elikhuselweyo njengelichiza phantsi kwegama lokurhweba ngeXenical nguRoche kumazwe amaninzi, kwaye kuyathengiswa ngaphezulu kwikhawuntara njengeAlli nguGlaxoSmithKline e-United Kingdom nase-United States.Its Umsebenzi oyintloko ukuthintela ukufakwa kwamafutha ku Ukutya komntu ngokusebenza njenge-lipase inhibitor, ngaloo ndlela kunciphisa umthamo we-caloric. Yenzelwe ukusetyenziswa ngokudibeneyo nomboneleli wokhathalelo wezempilo-ogadwe yinciphisa-ikhalori yokutya.
I-Orlistat powder sisithambiso esigciniweyo se-lipstatin, inhibitor yendalo enamandla e-pancreatic lipases esekwe kwi-bacterium Streptomyces toxytricini.However, ngenxa yobulula bayo kunye nokuzinza, i-orlistat powder yakhethwa ngaphezulu kwe-lipstatin yokuphuhliswa njengechiza elichasene nokukhuluphala.
I-Orlistat powder isetyenziselwa ukunceda ukunciphisa umzimba, okanye ukunceda ukunciphisa umngcipheko wokubuyisa ubunzima esele belahlekile. Eli liyeza kufuneka lisetyenziswe kunye nokutya okunekhalori okuncitshisiweyo. I-Orlistat yeyokusetyenziswa kuphela kubantu abadala.
I-Orlistat powder yinto eguqukayo enhibitor ye-lipases. Inika umsebenzi wayo wonyango kwi-lumen yesisu kunye namathumbu amancinci ngokwenza umdibaniso odibeneyo kunye nendawo esebenzayo ye-serine ye-gastric kunye ne-pancreatic lipases. Ii-enzymes ezingasebenziyo azifumaneki kumanqatha okutya e-hydrolyze ngendlela ye-triglycerides kwii-acids zamafutha asimahla kunye ne-monoglycerides. Njengoko i-triglycerides engafakwanga ingafakwanga, umphumo wekhalori onesiphumo unokuba nefuthe lokulawula ubunzima.
I-Orlistat powder isetyenziswe ngovavanyo oluvunyiweyo ngugqirha, utshintsho lokuziphatha, kunye nenkqubo yokutya encinci yeekhalori zokukunceda ukunciphisa umzimba. Isetyenziswe ngabantu abathile abatyebileyo, njengabo batyeba kakhulu okanye baneengxaki zonyango ezinxulumene nobunzima. Ukuthatha i-orlistat kunokukunceda ukuba ungazukubuyisa isisindo esilahlekileyo. Ukuphulukana nobunzima kunye nokuwugcina kude kunganciphisa umngcipheko omkhulu wezempilo oza nokukhuluphala, kubandakanya isifo sentliziyo, isifo seswekile, uxinzelelo lwegazi oluphezulu, kunye nobomi obufutshane.
Abantu banokucela "i-Dose Orlistat iyasebenza ngokwenene?".
Ukuba isetyenziswe kunye neqhinga elongezelelweyo lokulahleka kwesisindo, i-Orlistat ibonakalisiwe ukuba iyasebenza ekuncedeni ukunciphisa umzimba.
Olunye uphononongo lufumanise ukuba abantu abathathe i-Orlistat kwaye baqhubeka nokutya okune-calorie ephantsi baphulukene ne-1.25 yelitye (8.1kg) ngonyaka, eyayiyi-6lb (2.8kg) ngaphezulu kwabo bangazange bathathe i-Orlistat ngexesha elinye.
Olunye uphononongo lufumanise ukuba abaguli abangama-743 abatyebileyo abathatha i-Orlistat yokunciphisa umzimba baye baphulukana nomndilili we-10.3kg ubunzima emva konyaka. Oku kuthelekiswa nezigulana ezi-6.1kg ezingathathi i-Orlistat elahlekileyo.
Olunye uphononongo luye lwafumanisa ukuba abantu abalandela le khosi yonyango banokuphulukana ukuya kwi-10% yobunzima bomzimba wabo ngonyaka.
Njengamayeza amaninzi, kukho ezinye zeziphumo ze-Orlistat. Iziphumo eziqhelekileyo ezirekhodiweyo ze-Orlistat zokuthatha i-Orlistat zihlangabezana nentloko.
[1] I-Orlistat i-120mg capsule blister pack ". TGA. 11 Epreli 2000. Ibuyisiwe nge-18 ku-Epreli 2018.
[2] JA Menendez; L. Vellon; R. Lupu (2005). "Izenzo ze-Antitumoral ze-anti-obesity drug orlistat (i-Xenical TM) kwiiseli zomhlaza wamabele: ukuvinjelwa kokuqhubela phambili komjikelo weseli, ukukhuthaza ukubhubha kweseli kwe-apoptotic kunye ne-PEA3-mediated transcriptional transcriptional ye-Her2 / neu (erbB-2) oncogene". Izibhengezo zeOncology. 16 (8): 1253-1267. ikhonkco: 10.1093 / annonc / mdi239. IINKCUKACHA:
[3] ”I-FDA ivuma i-Orlistat yoSetyenziso oluNgaphezulu kweye-Counter” (Imithombo yeendaba). Ulawulo lwezoKutya kunye noLawulo lweziyobisi (FDA). Nge-7 kaFebruwari 2007. Ibuyisiwe nge-7 kaFebruwari 2007.
[4] USawule, uStephanie (7 ngoFebruwari 2007). "Amachiza okuThoba umzimba athengiswe ngaphezulu kweKhawuntari". INew York Times. Ukufunyanwa kwe-10 kaFebruwari 2007.